Victrex PLC (VCT)

Industry Specialty Chemicals


This stock can be held in an Investment ISA, SIPP and Investment Account
Sell

646.00p

Buy

648.00p

arrow-down-8.00p (-1.22%)

Prices updated at 12 Dec 2025, 16:35 GMT
| Prices minimum 15 mins delay
|
Prices in GBX

Victrex PLC manufactures and sells high performance polymers and provides PEEK and PAEK polymer solutions. It operates in two segments namely, Industrial (Victrex Polymer Solutions) and Medical (Invibio Biomaterial Solutions).

Income statement

20242025
296m296m
134m133m
60m48m
20.3616.33
17m28m
49m61m
Sales, General and administrative57m65m
Interest expenses2m2m
Provision for income taxes8m9m
Operating expenses74m84m
Income before taxes23m34m
Net income available to common shareholders17m28m
0.1980.32
Net interest income-1m-2m
Advertising and promotion--
Net investment income, net--
Realised capital gains (losses), net--
Total benefits, claims and expenses--
Earnings per share (diluted)0.1970.318
Free cash flow per share0.58830.7454
Book value/share5.29674.9947
Debt equity ratio0.0893710.068281

Balance sheet

20242025
Current assets201m185m
Current liabilities46m62m
Total capital494m456m
Total debt50m49m
Total equity461m434m
Total non current liabilities--
Loans33m23m
Total assets592m567m
Total liabilities--
Cash and cash equivalents29m24m
Common stock87m87m

Cash flow

20242025
Cash at beginning of period33m29m
Cash dividends paid-52m-52m
51m49m
Investments (gains) losses-35m-22m
29m24m
Net income--
84m71m
-33m-22m
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.


Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.